Pat Anson, writing for Pain News Network:
The FDA began monitoring social media – what it calls “proactive pharmacovigilance” – about a decade ago, primarily as an early warning system for adverse events involving medication.
I wasn't aware of this online monitoring by the FDA until now, but it makes sense that they're doing it. Maybe the organization has observed the fact that coverage about drugs (including psychedelics) has become more favorable in the media during the last 10 years.
It's also telling that the FDA seems to be going specifically after kratom vendors.